| RS2518385575 |
ARSL
|
Health Risk |
Likely pathogenic |
Chondrodysplasia punctata, brachytelephalangic |
| RS2518393305 |
SHANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518395818 |
DEPDC5
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2518397146 |
SHANK3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2518404916 |
LOC126863188;SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518405969 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2518417913 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518418341 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518418801 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2518420699 |
MSL3
|
Health Risk |
Pathogenic |
Basilicata-Akhtar syndrome, Basilicata-Akhtar syndrome |
| RS2518423160 |
MSL3
|
Health Risk |
Likely pathogenic |
Basilicata-Akhtar syndrome, Nonpapillary renal cell carcinoma |
| RS2518425246 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518425257 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518425438 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518425642 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518426396 |
MSL3
|
Health Risk |
Pathogenic |
Basilicata-Akhtar syndrome, Basilicata-Akhtar syndrome |
| RS2518426434 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518426468 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518426728 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518426852 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518427127 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518427323 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518427341 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518427524 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518427933 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518428548 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518428922 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518428935 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518429694 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Schizophrenia 15 |
| RS2518429854 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518429888 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518429961 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518430518 |
SHANK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Phelan-McDermid syndrome, Intellectual disability |
| RS2518433178 |
MYO18B
|
Health Risk |
Pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS2518433736 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2518433950 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2518434727 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518435267 |
MSL3
|
Health Risk |
Pathogenic |
Basilicata-Akhtar syndrome, Basilicata-Akhtar syndrome |
| RS2518435287 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518436090 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518436598 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2518436718 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518437138 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS2518438898 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518438901 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518439090 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518439217 |
SHANK3
|
Health Risk |
Likely pathogenic |
SHANK3-related disorder, SHANK3-related disorder |
| RS2518439281 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518439453 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518439785 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2518439821 |
SHANK3
|
Health Risk |
Likely pathogenic |
SHANK3-related disorder, SHANK3-related disorder |
| RS2518440963 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518448686 |
ACR
|
Health Risk |
Pathogenic |
Spermatogenic failure 87, Spermatogenic failure 87 |
| RS2518460852 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518461134 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518465594 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518467155 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518468186 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518469618 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518471430 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2518472366 |
HCCS
|
Health Risk |
Likely pathogenic |
Linear skin defects with multiple congenital anomalies 1, Linear skin defects with multiple congenital anomalies 1 |
| RS2518472872 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518474197 |
NLGN4X
|
Health Risk |
Likely pathogenic |
Autism, susceptibility to |
| RS2518482190 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518487129 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518487678 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518487922 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2518488062 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518488079 |
MLC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518488096 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518488260 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518488310 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518488607 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518488789 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518488795 |
MLC1
|
Health Risk |
Likely pathogenic |
— |
| RS2518492759 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518492806 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518492977 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518492991 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS2518497064 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518498625 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518498635 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518499632 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518499685 |
PDHA1
|
Health Risk |
Pathogenic |
— |
| RS2518499712 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518499772 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518500152 |
ANOS1
|
Health Risk |
Likely pathogenic |
— |
| RS2518500156 |
ANOS1
|
Health Risk |
Likely pathogenic |
— |
| RS2518500437 |
PDHA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518502222 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518502381 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518502640 |
SNAP29
|
Health Risk |
Pathogenic |
— |
| RS2518503103 |
SNAP29
|
Health Risk |
Pathogenic |
— |
| RS2518503242 |
DRG1
|
Health Risk |
Likely pathogenic |
Tan-Almurshedi syndrome, Tan-Almurshedi syndrome |
| RS2518505616 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518505642 |
PDHA1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2518505720 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518507553 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518507652 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518507871 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |